BJ
VIVO

BlackRock Japan’s Meridian Bioscience Inc VIVO Stock Holding History

BlackRock Japan’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-866
Closed -$23K – 1480
2013
Q4 		$23K Sell
866
-1,748
-67% -$43K ﹤0.01% 1214
2013
Q3 		$62K Sell
2,614
-540
-17% -$12.6K ﹤0.01% 1091
2013
Q2 		$68K Buy
+3,154
New +$68K ﹤0.01% 1038

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

BlackRock Japan's VIVO Position: Q1 2014 in Review

BlackRock Japan sold out of Meridian Bioscience Inc (VIVO) in Q1 2014, closing a stake of 866 shares — an estimated $23K sold.

BlackRock Japan first reported a position in VIVO in Q2 2013 and held it in 3 quarters. The position peaked at $68K in Q2 2013. 166 funds tracked by Wall St. Rank hold VIVO as of Q1 2014.

  • BlackRock Japan reported no remaining Meridian Bioscience Inc position as of Q1 2014 after selling out during the quarter.
  • BlackRock Japan sold 866 Meridian Bioscience Inc shares in Q1 2014, an estimated $23K.
  • BlackRock Japan first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 3 quarters.
  • BlackRock Japan's Meridian Bioscience Inc position peaked at $68K in Q2 2013.
  • 166 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2014.

Based on BlackRock Japan's 13F filing for Q1 2014, filed 2 May 2014.